Intraperitoneal chemotherapy

This publication has 30 references indexed in Scilit:

• A Phase II Trial of Intraperitoneal Cisplatin and Etoposide as Consolidation Therapy in Patients with Stage II–IV Epithelial Ovarian Cancer Following Negative Surgical Assessment
  Gynecologic Oncology, 1998
• High-Intensity Intravenous Cyclophosphamide and Cisplatin, Interim Surgical Debulking, and Intraperitoneal Cisplatin in Advanced Ovarian Carcinoma: A Pilot Trial with Ten-Year Follow-up
  Gynecologic Oncology, 1997
• Cyclophosphamide and Cisplatin Compared with Paclitaxel and Cisplatin in Patients with Stage III and Stage IV Ovarian Cancer
  New England Journal of Medicine, 1996
• Is There a Role for Intraperitoneal Therapy in the Management of Gastrointestinal Malignancies?
  Cancer Investigation, 1995
• A phase I trial of immediate postoperative intraperitoneal floxuridine and leucovorin plus systemic 5-fluorouracil and levamisole after resection of high risk colon cancer
  Cancer, 1994
• Salvage Intraperitoneal Therapy of Ovarian Cancer Employing Cisplatin and Etoposide: A Gynecologic Oncology Group Study
  Gynecologic Oncology, 1993
• Intraperitoneal therapy for treatment of malignant disease principally confined to the peritoneal cavity
  Critical Reviews in Oncology/Hematology, 1993
• Efficacy of cisplatin-based intraperitoneal chemotherapy as treatment of malignant peritoneal mesothelioma
  Zeitschrift für Krebsforschung und Klinische Onkologie, 1992
• Characteristics of patients with small-volume residual ovarian cancer unresponsive to cisplatin-based ip chemotherapy: Lessons learned from a gynecologic oncology group phase II trial of ip cisplatin and recombinant α-interferon
  Gynecologic Oncology, 1992
• Cisplatin administered by the intracavitary route as treatment for malignant mesothelioma
  Cancer, 1986